Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent.
Denoyer D, Labarre P, Papon J, Miot-Noirault E, Galmier MJ, Madelmont JC, Chezal JM, Moins N. Denoyer D, et al. Among authors: madelmont jc. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Nov 15;875(2):411-8. doi: 10.1016/j.jchromb.2008.09.021. Epub 2008 Sep 25. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18838313
Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.
Maisonial A, Kuhnast B, Papon J, Boisgard R, Bayle M, Vidal A, Auzeloux P, Rbah L, Bonnet-Duquennoy M, Miot-Noirault E, Galmier MJ, Borel M, Askienazy S, Dollé F, Tavitian B, Madelmont JC, Moins N, Chezal JM. Maisonial A, et al. Among authors: madelmont jc. J Med Chem. 2011 Apr 28;54(8):2745-66. doi: 10.1021/jm101574q. Epub 2011 Mar 21. J Med Chem. 2011. PMID: 21417462
Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.
Maisonial A, Billaud EM, Besse S, Rbah-Vidal L, Papon J, Audin L, Bayle M, Galmier MJ, Tarrit S, Borel M, Askienazy S, Madelmont JC, Moins N, Auzeloux P, Miot-Noirault E, Chezal JM. Maisonial A, et al. Among authors: madelmont jc. Eur J Med Chem. 2013 May;63:840-53. doi: 10.1016/j.ejmech.2012.11.047. Epub 2013 Mar 24. Eur J Med Chem. 2013. PMID: 23603044
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N, D'Incan M, Bonafous J, Bacin F, Labarre P, Moreau MF, Mestas D, Noirault E, Chossat F, Berthommier E, Papon J, Bayle M, Souteyrand P, Madelmont JC, Veyre A. Moins N, et al. Among authors: madelmont jc. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1478-84. doi: 10.1007/s00259-002-0971-6. Epub 2002 Sep 11. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397467 Clinical Trial.
A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.
Rapp M, Maurizis JC, Papon J, Labarre P, Wu TD, Croisy A, Guerquin-Kern JL, Madelmont JC, Mounetou E. Rapp M, et al. Among authors: madelmont jc. J Pharmacol Exp Ther. 2008 Jul;326(1):171-7. doi: 10.1124/jpet.108.137737. Epub 2008 Apr 14. J Pharmacol Exp Ther. 2008. PMID: 18411412
134 results